188 related articles for article (PubMed ID: 7479222)
1. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient].
Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M
Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
Holley JL; Nolan TA; Piraino B
Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin treatment of anemia associated with multiple myeloma.
Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
[TBL] [Abstract][Full Text] [Related]
8. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
House AA; Pham B; Pagé DE
Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
[TBL] [Abstract][Full Text] [Related]
9. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
[TBL] [Abstract][Full Text] [Related]
10. [The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin].
Ciepłuch H; Zaucha JM; Lysiak-Szydłowska W; Hellmann A
Pol Arch Med Wewn; 1995 Aug; 94(2):153-8. PubMed ID: 8596750
[TBL] [Abstract][Full Text] [Related]
11. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
13. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
15. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human erythropoietin (rHuEPO) on nutritional status of hemodialysis patients: investigation of direct anabolic effects of rHuEPO.
Usuba T; Kuno T; Higuchi T; Kikuchi F; Nagura Y; Kanmatsuse K; Takahashi S
Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1288-95. PubMed ID: 7853762
[TBL] [Abstract][Full Text] [Related]
17. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
Cascinu S; Fedeli A; Del Ferro E; Luzi Fedeli S; Catalano G
J Clin Oncol; 1994 May; 12(5):1058-62. PubMed ID: 8164030
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant human erythropoietin in the treatment of anaemia of prematurity.
Polkowska G; Wójcik-Skierucha E; Furmaga-Jabłońska W
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):178-83. PubMed ID: 16146073
[TBL] [Abstract][Full Text] [Related]
20. [Erythropoietin treatment of tumor-associated anemia in patients with multiple myeloma].
Ludwig H; Fritz E; Kotzmann H; Gisslinger H
Onkologie; 1990 Feb; 13(1):46-9. PubMed ID: 2186325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]